COMMUNIQUÉS West-GlobeNewswire

-
ProMIS Neurosciences Announces Successful Humanization of Lead Product Candidate PMN310 for Alzheimer's Disease
19/09/2017 - 13:30 -
MPI - LiPlaCis Phase 2 Recruitment Ongoing in DRP Screened Breast Cancer Patients: Relevant Clinical Benefits in 3 out of 5 Treated Patients
19/09/2017 - 12:45 -
Dangote Foundation, GBCHealth, join forces to build Coalition on Health
19/09/2017 - 11:52 -
Glycotope outlicenses GlycoExpress® Cell Line to Airway Therapeutics
19/09/2017 - 10:30 -
FIT Biotech: Conversion of FIT Biotech Oy's Convertible Capital Notes into shares
19/09/2017 - 09:00 -
TiGenix Business and Financial Update for the First Half 2017
19/09/2017 - 07:00 -
Rapport d'activité et rapport financier de TiGenix pour le premier semestre de 2017
19/09/2017 - 07:00 -
Summit Therapeutics Announces Closing of its ADS Public Offering Raising USD20.1M Before Expenses
18/09/2017 - 19:00 -
Sanofi : Disclosure of trading in own shares
18/09/2017 - 18:00 -
Sanofi : Déclaration des transactions sur actions propres
18/09/2017 - 18:00 -
Ossur Hf : Transactions in relation to share buyback program
18/09/2017 - 18:00 -
Novo Nordisk A/S - Share repurchase programme
18/09/2017 - 15:40 -
Medtronic Announces FDA Approval and U.S. Launch of Next Generation Spinal Cord Stimulator for Chronic Pain Management
18/09/2017 - 15:00 -
AroCell AB: New application for AroCell TK 210 ELISA opens new opportunities for drug development research
18/09/2017 - 14:15 -
Prothena Presents New Research Supporting Clinical Relevance of Cardiac Biomarker NT-proBNP in AL Amyloidosis
18/09/2017 - 14:00 -
Advanced Bifurcation Systems to Sponsor XIII European Bifurcation Club Meeting
18/09/2017 - 13:55 -
Immunocore and the Bill & Melinda Gates Foundation Collaborate to Develop Immunotherapies for Infectious Diseases
18/09/2017 - 13:00 -
Solon Eiendom ASA : Primary insider notification
18/09/2017 - 08:30 -
Cambridge Medical Robotics closes Series A fundraise with further $26 million
18/09/2017 - 08:00
Pages